Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/06/16/2464300/28235/en/Cornerstone-Pharmaceuticals-Announces-Published-Data-on-CPI-613-Devimistat-as-an-Effective-Approach-to-Targeting-Carcinoma-Catabolism-UPDATE.html
https://www.globenewswire.com/news-release/2022/06/01/2454159/28235/en/Cornerstone-Pharmaceuticals-to-Present-Pancreatic-Cancer-Clear-Cell-Sarcoma-and-Biliary-Tract-Cancer-Research-Featuring-CPI-613-Devimistat-at-the-2022-American-Society-of-Clinical-.html
https://www.globenewswire.com/news-release/2022/05/24/2449592/28235/en/European-Medicines-Agency-Grants-Orphan-Drug-Designation-to-Cornerstone-Pharmaceuticals-CPI-613-Devimistat-for-Treatment-of-Patients-with-Advanced-Unresectable-Biliary-Tract-Cancer.html
https://globenewswire.com/news-release/2017/06/05/1008222/0/en/Cornerstone-Pharmaceuticals-Inc-Announces-Corporate-Name-Change-to-Rafael-Pharmaceuticals-Inc.html